Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Cardiovasc Pharmacol ; 78(1): e147-e155, 2021 07 01.
Article in English | MEDLINE | ID: mdl-34173803

ABSTRACT

ABSTRACT: Urotensin II (UII) is involved in the formation of atherosclerosis, but its role in the stability of atherosclerotic plaques is unknown. The purpose of this study was to observe the dynamic changes in plasma UII and analyze its relationship to the stability of atherosclerotic plaques. One hundred thirty-five consecutive patients with acute coronary syndrome (ACS) were enrolled. The plasma UII levels were measured immediately after admission and during three-month follow-up. A vulnerable plaque model was established using local transfection of a recombinant P53 adenovirus into plaques in rabbits fed with a high-cholesterol diet and subjected to balloon arterial injury. The levels of plasma UII were measured weekly. The changes in plasma UII during the formation of atherosclerotic plaques and before and after plaque transfection were observed. The morphology of the plaques and the expression, distribution, and quantitative expression of UII in the plaques also were observed. Our results showed that the levels of plasma UII in patients with ACS at admission were lower than levels observed at the three-month follow-up. UII dynamic changes and its correlation with plaque stabilities were further verified in rabbits with atherosclerotic vulnerable plaques. The UII levels in rabbits were significantly decreased immediately after the P53 gene transfection, which led to plaque instability and rupture. These results suggested that UII expression was down-regulated in ACS, which may be related to its ability to modulate mechanisms involved in plaque stability and instability.


Subject(s)
Acute Coronary Syndrome/blood , Aortic Diseases/blood , Atherosclerosis/blood , Plaque, Atherosclerotic , Urotensins/blood , Acute Coronary Syndrome/diagnosis , Acute Coronary Syndrome/therapy , Adult , Aged , Aged, 80 and over , Animals , Aortic Diseases/genetics , Aortic Diseases/pathology , Atherosclerosis/genetics , Atherosclerosis/pathology , Biomarkers/blood , Case-Control Studies , Disease Models, Animal , Female , Humans , Male , Middle Aged , Prognosis , Rabbits , Rupture, Spontaneous , Time Factors , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Urotensins/genetics , Young Adult
2.
Front Immunol ; 12: 643894, 2021.
Article in English | MEDLINE | ID: mdl-33889153

ABSTRACT

Strong relationships have been found between appendicular lean mass (ALM) and bone mineral density (BMD). It may be due to a shared genetic basis, termed pleiotropy. By leveraging the pleiotropy with BMD, the aim of this study was to detect more potential genetic variants for ALM. Using the conditional false discovery rate (cFDR) methodology, a combined analysis of the summary statistics of two large independent genome wide association studies (GWAS) of ALM (n = 73,420) and BMD (n = 10,414) was conducted. Strong pleiotropic enrichment and 26 novel potential pleiotropic SNPs were found for ALM and BMD. We identified 156 SNPs for ALM (cFDR <0.05), of which 74 were replicates of previous GWASs and 82 were novel SNPs potentially-associated with ALM. Eleven genes annotated by 31 novel SNPs (13 pleiotropic and 18 ALM specific) were partially validated in a gene expression assay. Functional enrichment analysis indicated that genes corresponding to the novel potential SNPs were enriched in GO terms and/or KEGG pathways that played important roles in muscle development and/or BMD metabolism (adjP <0.05). In protein-protein interaction analysis, rich interactions were demonstrated among the proteins produced by the corresponding genes. In conclusion, the present study, as in other recent studies we have conducted, demonstrated superior efficiency and reliability of the cFDR methodology for enhanced detection of trait-associated genetic variants. Our findings shed novel insight into the genetic variability of ALM in addition to the shared genetic basis underlying ALM and BMD.


Subject(s)
Body Weight/genetics , Bone Density/genetics , Polymorphism, Single Nucleotide , Female , Genome-Wide Association Study , Humans , Male
3.
Pharm Biol ; 53(1): 117-24, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25255928

ABSTRACT

UNLABELLED: Abstract Context: Most of the present studies on the antitumor efficiency of Cymbopogon citratus (DC.) Stapf (Gramineae) are limited to its low-mass compounds, and little information about the antitumor activity of polysaccharides from this plant is available. OBJECTIVES: This study focused on the potential antitumor and immunomodulatory activities of polysaccharides (CCPS) from C. citratus. MATERIALS AND METHODS: CCPS was isolated using the water extraction-ethanol precipitation method. The sarcoma 180 (S180) cells-inoculated mice were intraperitoneally administrated with CCPS (30-200 mg/kg/d) for seven consecutive days. The effects of CCPS on tumor growth, thymus and spleen weights, splenocyte proliferation, and cytokine secretion in the tumor-bearing mice were measured. The cytotoxicity of CCPS (50-800 µg/mL) towards S180 cells was also studied. RESULTS: CCPS significantly inhibited the growth of the transplanted S180 tumors, with the inhibition rates ranging from 14.8 to 37.8%. Simultaneously, CCPS dose-dependently improved the immunity of the tumor-bearing mice. With the highest dose of 200 mg/kg/d, the thymus and spleen indices were increased by 21.9 and 91.9%, respectively; ConA- and LSP-induced splenocyte proliferations were increased by 32.7 and 35.3%, respectively. The secretions of interleukin 2 (IL-2), interleukin 6 (IL-6), interleukin 2 (IL-12), and tumor necrosis factor-α (TNF-α) were increased by 103.2, 40.2, 23.6, and 26.3%, respectively. Nevertheless, almost no toxicity of CCPS towards S180 cells was observed, with the maximal inhibition rate less than 15% at the CCPS concentration of 800 µg/mL. CONCLUSION: CCPS exhibited antitumor activity in vivo, and this activity might be achieved by immunoenhancement rather than direct cytotoxicity.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Cymbopogon/chemistry , Immunologic Factors/pharmacology , Polysaccharides/pharmacology , Animals , Antineoplastic Agents, Phytogenic/isolation & purification , Antineoplastic Agents, Phytogenic/therapeutic use , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Dose-Response Relationship, Drug , Immunologic Factors/isolation & purification , Immunologic Factors/therapeutic use , Male , Mice, Inbred Strains , Neoplasm Transplantation , Organ Size/drug effects , Plant Components, Aerial/chemistry , Polysaccharides/isolation & purification , Polysaccharides/therapeutic use , Sarcoma 180/drug therapy , Sarcoma 180/immunology , Sarcoma 180/pathology , Spleen/drug effects , Spleen/immunology , Spleen/pathology , Thymus Gland/drug effects , Thymus Gland/immunology , Thymus Gland/pathology
4.
Molecules ; 19(2): 2469-80, 2014 Feb 21.
Article in English | MEDLINE | ID: mdl-24566315

ABSTRACT

Lycorine, which is the most abundant alkaloid isolated from the Amaryllidaceae family of plants, reportedly exhibits promising anticancer activities. Herein, a series of novel lycorine derivatives were synthesized and evaluated for their in vitro inhibitory activities against seven different cancer cell lines, including A549, HCT116, SK-OV-3, NCI-H460, K562, MCF-7 and HL-60. The results indicated that compounds bearing diverse amine substituents at the C-2 position demonstrated good anticancer activities. The selectivity towards different cancer cell lines of the synthesized derivatives is discussed.


Subject(s)
Amaryllidaceae Alkaloids/administration & dosage , Amaryllidaceae Alkaloids/chemical synthesis , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/chemical synthesis , Phenanthridines/administration & dosage , Phenanthridines/chemical synthesis , Amaryllidaceae Alkaloids/chemistry , Antineoplastic Agents/chemistry , Cell Proliferation/drug effects , HCT116 Cells , Humans , Liliaceae/chemistry , Phenanthridines/chemistry , Plant Extracts/chemistry , Structure-Activity Relationship
5.
Pharm Biol ; 51(11): 1419-25, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23841520

ABSTRACT

CONTEXT: Alpinia oxyphylla Miquel (Zingiberaceae) is a traditional Chinese herbal medicine widely used for the treatment of intestinal disorders, urosis and diuresis. However, information about antioxidant and cytotoxic properties of its fruits remains to be elucidated. OBJECTIVE: The ethanol crude extract (CE) and its fractions [petroleum ether fraction (PF), ethyl acetate fraction (EF), n-butanol fraction (BF) and water fraction (WF) extracted by petroleum ether, ethyl acetate, n-butanol and water, respectively] of A. oxyphylla fruits were investigated for their antioxidant activity and cytotoxicity. MATERIALS AND METHODS: The total phenolic content (TPC) and antioxidant activity of the extracts were determined by Folin-Ciocalteu reagent, 1,1-diphenyl-2-picrylhydrazyl (DPPH(•)), Trolox equivalent antioxidant capacity and reducing power assay. Cytotoxicity of the extracts (0-200 µg/mL) was tested on six human cancer cell lines (breast cancer cell line, cervix carcinoma cell line, lung adenocarcinoma cell line, liver carcinoma cell line, gastric cancer cell line and colon cancer cell line) using the sulforhodamine B assay. RESULTS: The TPC of extracts varied from 8.2 to 20.3 mg gallic acid equivalents/g dry weight. DPPH radical scavenging effect of extracts decreased in the order of EF > BF > CE > PF > WF, with IC50 values ranging from 74.7 to 680.8 µg/mL. 2,2-azo-bis(3-Ethylbenzothiazoline-6-sulfoic acid) diammonium salt scavenging activity ranged from 0.118 to 0.236 mmol Trolox equivalence/mg extract. The extracts exhibited concentration-dependent reducing power, and EF showed the highest reducing ability. A satisfactory correlation (R(2) > 0.826) between TPC and antioxidant activity was observed. In addition, EF, PF and CE exhibited potent anticancer effects on six cancer cell lines with IC50 values ranging from 40.1 to 166.3 µg/mL. DISCUSSION AND CONCLUSION: The ethanol extract of A. oxyphylla fruit, especially the EF, was found to possess potent antioxidant and anticancer activities, and thus a great potential for the application in food and drug products.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Antioxidants/pharmacology , Drugs, Chinese Herbal/pharmacology , Ethanol/chemistry , Fruit , Plant Extracts/pharmacology , Solvents/chemistry , Alpinia , Antineoplastic Agents, Phytogenic/chemistry , Antioxidants/chemistry , Benzothiazoles/chemistry , Biphenyl Compounds/chemistry , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Chromans/chemistry , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/chemistry , Humans , Inhibitory Concentration 50 , Oxidation-Reduction , Phenols/pharmacology , Phytotherapy , Picrates/chemistry , Plant Extracts/chemistry , Plants, Medicinal , Sulfonic Acids/chemistry
6.
Fitoterapia ; 83(7): 1281-5, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22668973

ABSTRACT

An aqueous ethanol extract of Artemisia argyi inhibited the aminoacylation activity of LeuRS from Giardia lamblia (GlLeuRS). The bioassay-guided fractionation of the extract led to the isolation of 3,5-dicaffeoylquinic acid (1), with an IC50 of 5.82 µg/mL. The ester derivatives of 1 were also found to possess strong anti-GlLeuRS effects, with IC50 values of 1.79, 5.51 and 2.56 µg/mL respectively. Anti-giardial assay showed that the derivatives, especially 3,5-dicaffeoylquinic acid propyl ester (4) (IC50=4.62 µg/mL), were effective at killing G. lamblia.


Subject(s)
Antiprotozoal Agents/pharmacology , Artemisia/chemistry , Chlorogenic Acid/analogs & derivatives , Giardia lamblia/drug effects , Leucine-tRNA Ligase/antagonists & inhibitors , Plant Extracts/pharmacology , Aminoacylation , Antiprotozoal Agents/isolation & purification , Chlorogenic Acid/isolation & purification , Chlorogenic Acid/pharmacology , Giardia lamblia/genetics , Parasitic Sensitivity Tests , Plant Extracts/chemistry
7.
Bioelectrochemistry ; 74(2): 223-6, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18984070

ABSTRACT

A simple, polishable and renewable DNA biosensor was fabricated based on a zirconia modified carbon paste electrode. Zirconia was mixed with graphite powder and paraffin wax to produce the paste for the electrode, and response-optimized at 56% graphite powder, 19% ZrO(2) and 25% paraffin wax. An oligonucleotide probe with a terminal 5'-phosphate group was attached to the surface of the electrode via the strong affinity of zirconia for phosphate groups. DNA immobilization and hybridization were characterized by cyclic voltammetry and differential pulse voltammetry, using methylene blue as indicator. Examination of changes in response with complementary or non-complementary DNA sequences showed that the developed biosensor had a high selectivity and sensitivity towards hybridization detection (< or =2x10(-10) M complementary DNA detectable). The surface of the biosensor can be renewed quickly and reproducibly (signal RSD+/-4.6% for five successive renewals) by a simple polishing step.


Subject(s)
Electrochemistry/methods , Electrodes , Nucleic Acid Hybridization/methods , Zirconium , Biosensing Techniques/methods , Carbon , Equipment Reuse , Oligonucleotide Probes
SELECTION OF CITATIONS
SEARCH DETAIL
...